COMBINED SPIRONOLACTONE AND CONVERTING‐ENZYME INHIBITOR THERAPY FOR REFRACTORY HEART FAILURE

Hamid Ikram, Mark Webster, M. Gary Nicholls, G. R. J. Lewis, Mark Richards, Ian Crozier

Australian and New Zealand Journal of Medicine · 1986 · 35 citations · 6 references

Concepts

Abstract

Three cases are described of severe congestive heart failure which failed to respond to digitalis, high doses of loop diuretics, and converting-enzyme inhibitors. The addition of spironolactone produced a substantial diuresis associated with clinical and radiological improvement in each case. Although a reversible deterioration in renal function was observed, this drug combination represents a therapeutic option in end-stage heart failure.

References

6